Health Innovation Roundup: October 17, 2018

Each week Taproot brings together the latest on the research, technology, companies and people changing health and healthcare for the better in Edmonton.

Here are some highlights from this week’s Health Innovation Roundup:

News

• Edmonton to establish first chair position for lymphatic disorders research
• Two health tech companies are presenting at Startup Week Launch Party 9: Hölmetrics and Medo
• Find out what to look for in mental well-being apps
• Edmonton will host the 2019 SingularityU Canada Summit on April 23 and 24. The organization “empowers individuals and organizations to discover and develop breakthrough solutions using rapidly evolving technologies like artificial intelligence, robotics, and digital biology.”
• The University of Alberta’s faculty of nursing has held on to the second spot in Maclean’s university rankings.
• Alberta Enterprise is conducting the 2018 Alberta Tech Deal Flow Study to help investors and key decisions makers support Alberta’s tech companies. Take the survey here.

Events

• Launch Party Edmonton 9 takes place on Oct. 18 at Enbridge Centre, part of Edmonton Startup Week.
• The Rising Stars Health Innovations Symposium will take place on Oct. 23 at the Chateau Louis Conference Centre. Tickets range from $60 to $75.
• Edmonton will be host to the 2019 Canadian Agency for Drugs and Technologies in Health Symposium from April 14 to 16, 2019. The deadline for abstract submissions is Oct. 26.
• The Glenrose Rehabilitation Hospital will be hosting Spotlight on Innovation: Health to Home at the Westin Hotel on Nov. 7. The event will be focused on solving the challenges people with disabilities face transitioning from healthcare settings to their homes.

The Health Innovation Roundup, sponsored by Health City, is a weekly email newsletter published by Taproot Edmonton.

Sign up to get the full edition delivered directly to your inbox.

If you have a suggestion for a future edition of the roundup, send it to hello@taprootedmonton.ca for consideration.